# OmegAD (Omega-3 and Alzheimer's Disease)

> **NCT00211159** · NA · COMPLETED · sponsor: **Karolinska University Hospital** · enrollment: 204 (—)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** EPAX 1050TG

## Key facts

- **NCT ID:** NCT00211159
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 204 (—)
- **Last updated:** 2017-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211159, "OmegAD (Omega-3 and Alzheimer's Disease)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00211159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*